NeuroSense’s ALS drug PrimeC shows success in phase 2b, eyes final trial

PrimeC has been given an ‘Orphan Drug’ status by the FDA (Food and Drug Administration) and EMA (European Medicines Agency).

PrimeC is a novel therapy with a multi-targeted approach to treat ALS.

PrimeC is a novel therapy with a multi-targeted approach to treat ALS.

(photo credit: NeuroSense Therapeutics Ltd.)

ByABIGAIL RUBINSTEIN

MARCH 1, 2025 14:10

Updated: MARCH 2, 2025 16:54

RECOMMENDED STORIES

People applaud as Taoiseach Simon Harris looks on after receiving a majority parliamentary vote to become the next Taoiseach (Prime Minister) of Ireland, in Dublin, Ireland, April 9, 2024.

Ireland becomes first European country to introduce ban on trade, imports from Israeli settlements

JUNE 26, 2025

Syria’s interim President Ahmed al-Sharaa looks on as he attends the “Aleppo, Key to Victory” celebration marking Syria’s liberation, in Aleppo, Syria May 27, 2025.

'Every blow to Iran is a benefit': Why Syria allowed Israel bypass its airspace to strike Iran

JUNE 26, 2025

IAF fighter jets taking off for strikes in Iran, June 16, 2025.

'Tehran is beautiful from above, I hope to visit one day' Israeli pilot says after strike on Iran

JUNE 26, 2025

Map showing the range of Israeli strikes on Iran, June 27, 2025.

IDF releases details of damage to Iran's nuclear, missile production sites

JUNE 27, 2025

Hot Opinion

Now that the existential Iranian threat is over, it's time for Netanyahu to resign

ByJPOST EDITORIAL

Amotz Asa-El

Bibi Netanyahu, it's time for you to retire

Netanyahu must use displayed courage vis-à-vis Iran in Gaza war

Why world media blaming Israel for US striking Iran is scary